Torvacard Cristal coated tablets 10 mg. №90

$58.00

Manufacturer: CzechRepublic

Category:

Description

Prevention of cardiovascular disease. For adult patients without clinically pronounced coronary heart disease but with several risk factors for coronary heart disease, such as age, smoking, arterial hypertension, low HDL or early ischemic heart disease, the occurrence of myocardial infarction; reducing the risk of stroke; reducing the risk of revascularization and angina. For patients with type II diabetes mellitus and without clinically pronounced coronary heart disease, but with several risk factors for coronary heart disease, such as retinopathy, albuminuria, tobacco or arterial hypertension, the drug Torvacard Crystal is indicated for: reduction of infarction; reducing the risk of stroke. For patients with clinically pronounced coronary heart disease, Torvakard Crystal is indicated for: reducing the risk of non-lethal myocardial infarction; reducing the risk of lethal and non-lethal stroke; reducing the risk of revascularization; reducing the risk of hospitalization due to congestive heart failure; reducing the risk of angina. Hyperlipidemia. In addition to diet, to reduce the levels of total cholesterol, LDL cholesterol, apolipoprotein B and triglycerides, and to increase HDL cholesterol in patients with primary hypercholesterolemia (heterozygous family and non-familial class II and . As a supplement to the diet for the treatment of patients with elevated serum triglyceride levels (type IV according to Fredrickson’s classification). For the treatment of patients with primary dysbitalipoproteinemia (type i according to Fredrickson’s classification) when dieting is not effective enough. To reduce total cholesterol and LDL cholesterol in patients with homozygous familial hypercholesterolemia in addition to other lipid-lowering treatments (such as LDL apheresis) or if such treatments are unavailable. In addition to the diet to reduce total cholesterol, LDL cholesterol and apolipoprotein B in boys and girls after menstruation at the age of 10 to 17 years with heterozygous familial hypercholesterolemia, if after the appropriate diet, cholesterol results in the following: / dl or b) LDL cholesterol ³ 160 mg / dl and: a family history of early cardiovascular disease or two or more other risk factors for cardiovascular disease present in a pediatric patient.